TuHURA Biosciences Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +27.6% | +206.9% | +7.2% | -33.2% | +382.3% | -26.7% | +136.5% | -25.8% | +6.4% | +8.6% | +6.9% | |
| – | +51.5% | +346.6% | +4.4% | -37.0% | +463.0% | -27.0% | -12.5% | -72.1% | +31.9% | +51.1% | -76.3% | |
| – | +204.6% | +578.0% | +10.0% | -38.5% | +319.1% | -50.9% | +36.9% | -68.3% | +34.2% | +74.0% | -84.2% | |
| – | +204.6% | +578.0% | +10.0% | -38.5% | +319.1% | -50.9% | +36.9% | -68.3% | +34.2% | +74.0% | -84.2% | |
| – | – | +224.7% | – | – | -13.7% | -57.1% | +3,037.1% | -92.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +0.0% | -20.8% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | +0.0% | +36.5% | +0.0% | +0.0% | |
| – | -41.5% | +478.4% | -79.4% | +0.0% | +119.7% | -11.0% | +217.3% | -41.2% | -28.0% | +1.5% | +103.3% | |
| – | -43.9% | +158.9% | -53.3% | +140.3% | -1.8% | -10.3% | +217.3% | -41.8% | -33.0% | +2.5% | +52.5% | |
| – | – | – | – | – | – | +3.0% | +239.6% | +3.4% | -31.4% | -47.8% | +3.5% | |
| – | -42.6% | -5.1% | +35.0% | -41.9% | +145.8% | -2.2% | +18.2% | +13.2% | -8.7% | +4.9% | -22.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -54.9% | +761.0% | -32.5% | +97.3% | -13.7% | +24.8% | +10.8% | -20.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +152.4% | +9,724.3% | -87.0% | +38.1% | +1,839.8% | +2.6% | +2.6% | +13.7% | -5.4% | +25.2% | +6.6% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.